MedTrace Logo

Strive Cardio for Endometrial Cancer Survivors

NCT06534008 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2025-11-20

No results posted yet for this study

Summary

STRIVE Cardio is a 12-week exercise intervention study with the goal to improve functional fitness and cardiovascular health for women who have completed treatment for non-metastatic endometrial cancer within the last five years and are currently in remission. Measures will include a functional fitness test, carotid-femoral pulse wave velocity, brachial artery flow mediated dilation, and a blood draw. Participants will be provided resistance bands, a dumbbell, and a Fitbit to keep. Participants will be compensated $50 for each of their two in-person visits.

Conditions

Interventions

BEHAVIORAL

12-week home-based exercise intervention

All participants will be given the same 12-week distance-based exercise intervention.

Sponsors & Collaborators

  • Jess S. Gorzelitz

    lead OTHER

Principal Investigators

  • Jess Gorzelitz, PHD, MS · University of Iowa

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-23
Primary Completion
2025-11-17
Completion
2025-11-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06534008 on ClinicalTrials.gov